Panel Discussion: Innovative Technology Headwinds and Tailwinds

Tuesday, March 11, 2025

8:32 AM – 8:50 AM ET

Panel Moderator(s)

Dorothy B. Abel, BSBME

Partner
Abel and Wolf Consulting
Santa Rosa, California, United States

Disclosure information not submitted.
Ron Waksman, MD, MSCAI

Director, Cardiovascular Research and Advanced Education
MedStar Washington Hospital Center, MedStar Heart and Vascular Institute
Washington, District of Columbia, United States

Disclosure(s): Abbott Vascular: Grant/Research Support (Ongoing); Biotronik: Consultant (Ongoing), Grant/Research Support (Ongoing); Boston Scientific Corporation: Consultant (Ongoing), Grant/Research Support (Ongoing); Chiesi USA: Grant/Research Support (Ongoing)

Panel Discussant(s)

Yuval Binur, PhD

Managing Partner
Arsuf Global Partners
NEW YORK, New York, United States

Disclosure(s): No financial relationships to disclose
Chip Hance, BS, MBA

CEO
Regatta Medical
Bannockburn, Illinois, United States

Disclosure(s): No financial relationships to disclose
Margaret Kayo, PhD, MBA

Regulatory Affairs
HighLife / Margaret Inc
St Augustine, Florida, United States

Disclosure(s): HighLifeSAS: Employee (Ongoing); JenaValve Technology Inc: Consulting Fees (e.g., advisory boards) (Ongoing)
Katherine Kumar, PhD, RAC

Sr. EVP
4C Medical Technologies, Inc.
Minnetonka, Minnesota, United States

Disclosure(s): No financial relationships to disclose
Nikolai Nikitin, MD

President
Clinical Accelerator

Disclosure(s): No financial relationships to disclose
Semih Oktay, PhD

President
Cardiomed Device Consultants
Annapolis, Maryland, United States

Disclosure(s): I am a regulatory consultant to many cardiovascular device manufacturers: Consultant (Ongoing)
Stanton J. Rowe, PhD

CEO
NXT Biomedical
Irvine, California, United States

Disclosure(s): Gradient Denervation: Director (Ongoing), Ownership Interest (stocks, stock options, patent or other intellectual property or other ownership interest excluding diversified mutual funds) (Ongoing); Nidus Biomedical: Employee (Ongoing), Salary (Ongoing), Stock-privately held company (Ongoing); Symbiosis Ltd: Consultant (Ongoing), Ownership Interest (stocks, stock options, patent or other intellectual property or other ownership interest excluding diversified mutual funds) (Ongoing); Vivifi Medical: Director (Ongoing), Ownership Interest (stocks, stock options, patent or other intellectual property or other ownership interest excluding diversified mutual funds) (Ongoing), Stock-privately held company (Ongoing)
Mark A. Turco, MD

CEO & President
JC Medical and Genesis MedTech
Providence, Rhode Island, United States

Disclosure(s): No financial relationships to disclose

Disclosure(s):

Ron Waksman, MD, MSCAI: Abbott Vascular: Grant/Research Support (Ongoing); Biotronik: Consultant (Ongoing), Grant/Research Support (Ongoing); Boston Scientific Corporation: Consultant (Ongoing), Grant/Research Support (Ongoing); Chiesi USA: Grant/Research Support (Ongoing)

Yuval Binur, PhD: No financial relationships to disclose

Chip Hance, BS, MBA: No financial relationships to disclose

Margaret Kayo, PhD, MBA: HighLifeSAS: Employee (Ongoing); JenaValve Technology Inc: Consulting Fees (e.g., advisory boards) (Ongoing)

Katherine Kumar, PhD, RAC: No financial relationships to disclose

Nikolai Nikitin, MD: No financial relationships to disclose

Semih Oktay, PhD: I am a regulatory consultant to many cardiovascular device manufacturers: Consultant (Ongoing)

Stanton J. Rowe, PhD: Gradient Denervation: Director (Ongoing), Ownership Interest (stocks, stock options, patent or other intellectual property or other ownership interest excluding diversified mutual funds) (Ongoing); Nidus Biomedical: Employee (Ongoing), Salary (Ongoing), Stock-privately held company (Ongoing); Symbiosis Ltd: Consultant (Ongoing), Ownership Interest (stocks, stock options, patent or other intellectual property or other ownership interest excluding diversified mutual funds) (Ongoing); Vivifi Medical: Director (Ongoing), Ownership Interest (stocks, stock options, patent or other intellectual property or other ownership interest excluding diversified mutual funds) (Ongoing), Stock-privately held company (Ongoing)

Mark A. Turco, MD: No financial relationships to disclose